Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP322030.RA3I1U7-3wqHw2nCtfC1l2-ltoFzdXc_aBNaB14lH2-Gk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP322030.RA3I1U7-3wqHw2nCtfC1l2-ltoFzdXc_aBNaB14lH2-Gk130_assertion type Assertion NP322030.RA3I1U7-3wqHw2nCtfC1l2-ltoFzdXc_aBNaB14lH2-Gk130_head.
- NP322030.RA3I1U7-3wqHw2nCtfC1l2-ltoFzdXc_aBNaB14lH2-Gk130_assertion description "[Plasma concentrations of O-methylated metabolites were measured by liquid chromatography with electrochemical detection in 173 patients with pheochromocytoma, including 38 with multiple endocrine neoplasia type 2 (MEN 2), 10 with neurofibromatosis type 1 (NF1), 66 with von Hippel-Lindau (VHL) syndrome, and 59 with mutations of SDHB or SDHD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP322030.RA3I1U7-3wqHw2nCtfC1l2-ltoFzdXc_aBNaB14lH2-Gk130_provenance.
- NP322030.RA3I1U7-3wqHw2nCtfC1l2-ltoFzdXc_aBNaB14lH2-Gk130_assertion evidence source_evidence_literature NP322030.RA3I1U7-3wqHw2nCtfC1l2-ltoFzdXc_aBNaB14lH2-Gk130_provenance.
- NP322030.RA3I1U7-3wqHw2nCtfC1l2-ltoFzdXc_aBNaB14lH2-Gk130_assertion SIO_000772 21262951 NP322030.RA3I1U7-3wqHw2nCtfC1l2-ltoFzdXc_aBNaB14lH2-Gk130_provenance.
- NP322030.RA3I1U7-3wqHw2nCtfC1l2-ltoFzdXc_aBNaB14lH2-Gk130_assertion wasDerivedFrom befree-20140225 NP322030.RA3I1U7-3wqHw2nCtfC1l2-ltoFzdXc_aBNaB14lH2-Gk130_provenance.
- NP322030.RA3I1U7-3wqHw2nCtfC1l2-ltoFzdXc_aBNaB14lH2-Gk130_assertion wasGeneratedBy ECO_0000203 NP322030.RA3I1U7-3wqHw2nCtfC1l2-ltoFzdXc_aBNaB14lH2-Gk130_provenance.